Article 11 Feb 2020 "Misleading" To Suggest A Biosimilar Is Inferior, FDA Draft Guidance Warns United States Healthcare
Article 05 Feb 2020 FDA Issues Draft Guidance Regarding "Sameness" For Orphan Drug Gene Therapies United States Healthcare